Markets

Market Nav

News Details

19/06/2025 18:15

Natco Pharma - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015\r\n

Update on US FDA Audit at Pharma Division of the Company located at Kothur, Hyderabad